President Trump has announced a new tariff policy on generic medicines, setting a 0% tariff for the first two years and a 200% tariff thereafter, according to a Business-Today report published on July 22, 2026.
Tariff Schedule
The announced policy establishes a two-tier tariff structure:
| Period | Tariff Rate |
|---|---|
| First two years | 0% |
| Thereafter | 200% |
Missing Details
The Business-Today article did not provide additional specifics, such as which generic medicines are covered, the effective date of the announcement, or which enforcement bodies will implement the tariffs. The report also did not include any statements from President Trump or other officials, nor any analysis of potential impacts on trade partners.
Source Limitations
The original source text primarily contained boilerplate descriptions of the TOI Business Desk and links to financial calculators. The headline was the only substantive information about the tariff policy. Consequently, import/export professionals and trade policy analysts have limited actionable data from this report alone. Further official announcements or detailed regulatory filings would be necessary to assess the full implications for pharmaceutical trade.
Sources:
